Lanreotide supply disruption raises concerns over Cipla’s earnings (Soban News)

Cipla said supplies of its key US drug Lanreotide will remain constrained after its manufacturing partner paused production following USFDA observations​Cipla said supplies of its key US drug Lanreotide will remain constrained after its manufacturing partner paused production following USFDA observations ​Latest News [ SOBAN NEWS: International and National ]